Trial result ·
Platelet-Rich Fibrin in Surgical Wound Healing of Medication-Related Osteonecrosis of the Jaw: A Pilot Clinical Study.
Written based on 1 research study on PubMed, searched on 15 Nov 2026.
What was studied
This study looked at MRONJ, jaw bone damage linked to some drugs. The team tested platelet-rich fibrin, or PRF, as an add-on to surgery. The study took in 22 people and followed them forward in time. One group had surgery with PRF. The other group had surgery without it. Pain and healing were checked before surgery. They were checked again 14 days, 6 weeks and 6 months after surgery.
What they found
People given PRF had less pain after surgery. PRF also led to better healing in people with raised CRP. People with a higher BMI responded less well to PRF. Soft tissue healing and disease stage looked better with PRF. But these gaps could have been due to chance.
What it means for patients
The authors note there is still no standard treatment for MRONJ. They describe PRF as a cheap and safe add-on treatment. They say it may help patients. The main gain they point to is less pain.
Why it is not certain yet
Only 22 people took part in this study. The authors say all results should be read with care for this reason. Some of the gains with PRF could have been due to chance. The authors say larger studies at many centers must confirm the results.
The registered trial
The paper names this trial from a public trial registry. Its page shows who the trial is for, its sites and its status.
Source
Platelet-Rich Fibrin in Surgical Wound Healing of Medication-Related Osteonecrosis of the Jaw: A Pilot Clinical Study.
PubMed · PMID 42074292We restate facts from the source record in our own words. The original wording belongs to its publisher.
This page is not medical advice. Talk to your doctor about your own care.
Back to Osteonecrosis (avascular necrosis) publications